CIK 0001438533
- Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 262383102
- Phone
- +1 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,495,607
- in 10 filings, $79.5M under 10b5-1 plans
Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-08 | Squarer Ron Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | Orwin John A Director | Grant or award | +2,000 | 8,875 | ||
| 2019-05-08 | Orwin John A Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | Meckler Jeffrey A Director | Grant or award | +2,000 | 61,000 | ||
| 2019-05-08 | Meckler Jeffrey A Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | LYONS GARY A Director | Grant or award | +2,000 | 31,000 | ||
| 2019-05-08 | LYONS GARY A Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | KOZARICH JOHN W Director | Grant or award | +2,000 | 29,000 | ||
| 2019-05-08 | KOZARICH JOHN W Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | Coughlin Timothy P Director | Grant or award | +2,000 | 29,000 | ||
| 2019-05-08 | Coughlin Timothy P Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | Baynes Roy D. Director | Grant or award | +2,000 | 11,000 | ||
| 2019-05-08 | Baynes Roy D. Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-05-08 | ASELAGE STEVE Director | Grant or award | +2,000 | 259,642 | ||
| 2019-05-08 | ASELAGE STEVE Director | Grant or award · Employee stock option (right to buy) | +8,000 | 8,000 | ||
| 2019-02-19 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −1,250 | $21.52 | $27K | 13,810 |
| 2019-02-15 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −1,250 | $21.44 | $27K | 15,060 |
| 2019-02-12 | REED ELIZABETH E SVP, GC & Corporate Secretary | Sale | −884 | $21.50 | $19K | 14,558 |
| 2019-02-12 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −992 | $21.50 | $21K | 16,007 |
| 2019-02-12 | Clague Laura Chief Financial Officer | Sale | −1,016 | $21.50 | $22K | 10,000 |
Page 47 of 51 · 1,020 trades